Apexigen, Inc. Increase (Decrease) in Accrued Liabilities
Apexigen, Inc. reported Increase (Decrease) in Accrued Liabilities of -$17.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-08-10
- Apexigen, Inc. increase (decrease) in accrued liabilities for the quarter ending 2023-06-30 was -$9.00K.
- Apexigen, Inc. increase (decrease) in accrued liabilities for the quarter ending 2023-03-31 was -$8.00K, a 103.19% decline year-over-year.
- Apexigen, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was -$1.39M, a 194.49% decline year-over-year.
- Apexigen, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was -$873.00K, a 1811.76% decline year-over-year.
- Apexigen, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$3.13M, a 305.59% decline from fiscal 2021.
- Apexigen, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was $1.52M.
| Period end | Increase (Decrease) in Accrued Liabilities 1 month | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 4 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$17.00K 10-Q · filed 2023-08-10 | -$1.41M derived: sum of 3 quarters · filed 2023-08-10 | -$2.28M derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2023-03-31 | -$8.00K 10-Q · filed 2023-05-15 | -$1.40M derived: sum of 2 quarters · filed 2023-05-15 | -$2.27M derived: sum of 3 quarters · filed 2023-05-15 | -$3.39M derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2022-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$2.26M derived: sum of 2 quarters · filed 2023-02-22 | -$3.38M derived: sum of 3 quarters · filed 2023-08-10 | -$3.13M 10-K · filed 2023-02-22 | ||||||
| 2022-09-30 | -$873.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.99M derived: sum of 2 quarters · filed 2023-08-10 | -$1.74M 10-Q · filed 2022-11-14 | -$268.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2022-06-30 | -$1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$865.00K 10-Q · filed 2023-08-10 | $3.55M 10-Q · filed 2022-08-18 | $605.00K derived: sum of 3 quarters · filed 2023-08-10 | $656.00K derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | $251.00K 10-Q · filed 2023-05-15 | $2.31M 10-Q · filed 2022-05-23 | $1.72M derived: sum of 2 quarters · filed 2023-05-15 | $1.77M derived: sum of 3 quarters · filed 2023-05-15 | $1.76M derived: sum of 4 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.52M derived: sum of 2 quarters · filed 2023-02-22 | $1.51M derived: sum of 3 quarters · filed 2023-02-22 | $1.52M 10-K · filed 2023-02-22 | $37.50K 10-K · filed 2022-04-07 | |||||
| 2021-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $41.00K derived: sum of 2 quarters · filed 2022-11-14 | $51.00K 10-Q · filed 2022-11-14 | $10.00K 10-Q · filed 2021-12-09 | ||||||
| 2021-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-18 | $0.00 10-Q · filed 2022-08-18 | ||||||||
| 2021-03-31 | $10.00K 10-Q · filed 2022-05-23 | |||||||||
| 2020-09-30 | $0.00 10-Q · filed 2021-12-09 | |||||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 |